新型冠状病毒肺炎继发的点滴状银屑病
New-onset guttate psoriasis secondary to COVID-19.
作者信息
Rouai Meriem, Rabhi Faten, Mansouri Nada, Jaber Kahena, Dhaoui Raouf
机构信息
Department of Dermatology The Military Hospital of Tunis Tunis Tunisia.
Department of Pathology The Military Hospital of Tunis Tunis Tunisia.
出版信息
Clin Case Rep. 2021 Jul 28;9(7):e04542. doi: 10.1002/ccr3.4542. eCollection 2021 Jul.
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is associated with flares of psoriasis in patients with well-documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25-year-old male patient who presented a first-onset guttate psoriasis following a COVID-19 infection. We have not found previous descriptions of de novo guttate psoriasis post-COVID-19.
严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）是导致2019冠状病毒病（COVID-19）的病毒，在有充分记录的银屑病患者中，它与银屑病发作有关。病毒感染和用于治疗的药物，如羟氯喹，都被认为是病因。在此，我们报告一例25岁男性患者，他在感染COVID-19后首次出现点滴状银屑病。我们未发现之前有COVID-19后新发点滴状银屑病的描述。
Zotero 插件